{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:13:20Z","timestamp":1793366000655,"version":"4.5.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Fungal Biol."],"abstract":"<jats:p>\n                    Fluconazole-resistant\n                    <jats:italic>Candida parapsilosis<\/jats:italic>\n                    (FLZR-CP) outbreaks are a growing public health concern and have been reported in numerous countries. Patients infected with FLZR-CP isolates show fluconazole therapeutic failure and have a significantly increased mortality rate. Because fluconazole is the most widely used antifungal agent in most regions with outbreaks, it is paramount to restore its antifungal activity. Milbemycin oxim (MOX), a well-known canine endectocide, is a potent efflux pump inhibitor that significantly potentiates the activity of fluconazole against FLZR\n                    <jats:italic>C<\/jats:italic>\n                    .\n                    <jats:italic>glabrata<\/jats:italic>\n                    and\n                    <jats:italic>C<\/jats:italic>\n                    .\n                    <jats:italic>albicans.<\/jats:italic>\n                    However, the FLZ-MOX combination has not been tested against FLZR-CP isolates, nor is it known whether MOX may also potentiate the activity of echinocandins, a different class of antifungal drugs. Furthermore, the extent of involvement of efflux pumps\n                    <jats:italic>CDR1<\/jats:italic>\n                    and\n                    <jats:italic>MDR1<\/jats:italic>\n                    and ergosterol biosynthesis enzyme\n                    <jats:italic>ERG11<\/jats:italic>\n                    and their link with gain-of-function (GOF) mutations in their transcription regulators (\n                    <jats:italic>TAC1<\/jats:italic>\n                    ,\n                    <jats:italic>MRR1<\/jats:italic>\n                    , and\n                    <jats:italic>UPC2<\/jats:italic>\n                    ) are poorly characterized among FLZR-CP isolates. We analyzed 25 C.\n                    <jats:italic>parapsilosis<\/jats:italic>\n                    isolates collected from outbreaks in Turkey and Brazil by determining the expression levels of\n                    <jats:italic>CDR1<\/jats:italic>\n                    ,\n                    <jats:italic>MDR1<\/jats:italic>\n                    , and\n                    <jats:italic>ERG11<\/jats:italic>\n                    , examining the presence of potential GOF mutations in their transcriptional regulators, and assessing the antifungal activity of FLZ-MOX and micafungin-MOX against FLZR and multidrug-resistant (MDR)\n                    <jats:italic>C<\/jats:italic>\n                    .\n                    <jats:italic>parapsilosis<\/jats:italic>\n                    isolates.\n                    <jats:italic>ERG11<\/jats:italic>\n                    was found to be universally induced by fluconazole in all isolates, while expression of\n                    <jats:italic>MDR1<\/jats:italic>\n                    was unchanged. Whereas mutations in\n                    <jats:italic>MRR1<\/jats:italic>\n                    and\n                    <jats:italic>UPC2<\/jats:italic>\n                    were not detected,\n                    <jats:italic>CDR1<\/jats:italic>\n                    was overexpressed in three Brazilian FLZR-CP isolates, which also carried a novel\n                    <jats:italic>\n                      TAC1\n                      <jats:sup>L518F<\/jats:sup>\n                    <\/jats:italic>\n                    mutation. Of these three isolates, one showed increased basal expression of\n                    <jats:italic>CDR1<\/jats:italic>\n                    , while the other two overexpressed\n                    <jats:italic>CDR1<\/jats:italic>\n                    only in the presence of fluconazole. Interestingly, MOX showed promising antifungal activity against FLZR isolates, reducing the FLZ MIC 8- to 32-fold. However, the MOX and micafungin combination did not exert activity against an MDR\n                    <jats:italic>C<\/jats:italic>\n                    .\n                    <jats:italic>parapsilosis<\/jats:italic>\n                    isolate. Collectively, our study documents that the mechanisms underpinning FLZR are region specific, where\n                    <jats:italic>ERG11<\/jats:italic>\n                    mutations were the sole mechanism of FLZR in Turkish FLZR-CP isolates, while simultaneous overexpression of\n                    <jats:italic>CDR1<\/jats:italic>\n                    was observed in some Brazilian counterparts. Moreover, MOX and fluconazole showed potent synergistic activity, while the MOX-micafungin combination showed no synergy.\n                  <\/jats:p>","DOI":"10.3389\/ffunb.2022.906681","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T11:21:06Z","timestamp":1659007266000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Determinants of fluconazole resistance and the efficacy of fluconazole and milbemycin oxim combination against Candida parapsilosis clinical isolates from Brazil and Turkey"],"prefix":"10.3389","volume":"3","author":[{"given":"Farnaz","family":"Daneshnia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyha","family":"Hilmio\u011flu Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macit","family":"Ilkit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Shor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Nobrega","family":"de Almeida J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa M.","family":"Favarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo Lopes","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Arastehfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Perlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"382","DOI":"10.111\/myc.13053","article-title":"Epidemiological features of nosocomial candidaemia in neonates, infants and children: a multicentre study in Iran","volume":"63","author":"Ahangarkani","year":"2020","journal-title":"Mycoses"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e01001","DOI":"10.1128\/AAC.01001-20","article-title":"First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and\/or Y132F+K143R in Turkey","volume":"64","author":"Arastehfar","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/jac\/dkaa419","article-title":"Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge","volume":"76","author":"Arastehfar","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9120877","article-title":"Drug-resistant fungi: An emerging challenge threatening our limited antifungal armamentarium","volume":"9","author":"Arastehfar","year":"2020","journal-title":"Antibiotics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.676177","article-title":"Clonal candidemia outbreak by candida parapsilosis carrying Y132F in Turkey: evolution of a persisting challenge","volume":"11","author":"Arastehfar","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/jof5040090","article-title":"Identification of mycoses in developing countries","volume":"5","author":"Arastehfar","year":"2019","journal-title":"J. Fungi"},{"key":"B7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jgar.2019.04.003","article-title":"First multicenter report of in vitro resistance rates in candidaemia isolates in Turkey","volume":"18","author":"Arikan-Akdagli","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.1128\/AAC.00842-15","article-title":"Fluconazole and voriconazole resistance in Candida parapsilosis is conferred by gain-of-function mutations in MRR1 transcription factor gene","volume":"59","author":"Branco","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: Human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3201\/eid2409.180625","article-title":"Fluconazole-resistant Candida parapsilosis bloodstream isolates with Y132F mutation in ERG11 gene, south Korea","volume":"24","author":"Choi","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/mmy\/myaa098","article-title":"General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation","volume":"59","author":"Corzo-Leon","year":"2021","journal-title":"Med. Mycol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1177\/0091270003257456","article-title":"The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans","volume":"43","author":"Cotreau","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e03328","DOI":"10.1128\/mBio.03328-20","article-title":"Balancing positive and negative selection: In vivo evolution of Candida lusitaniae MRR1","volume":"12","author":"Demers","year":"2021","journal-title":"mBio"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e02036","DOI":"10.1128\/AAC.02036-20","article-title":"Hospital outbreak of fluconazole-resistant Candida parapsilosis: arguments for clonal transmission and long-term persistence","volume":"65","author":"Fekkar","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000268","article-title":"Gain-of-function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence","volume":"5","author":"Ferrari","year":"2009","journal-title":"PLoS Pathog."},{"key":"B16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/AAC.03470-14","article-title":"Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans","volume":"59","author":"Flowers","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1093\/jac\/dkw091","article-title":"Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in south Africa","volume":"71","author":"Govender","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1128\/AAC.04613-14","article-title":"Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system","volume":"59","author":"Grossman","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.644000","article-title":"Prevalence and antifungal susceptibility of Candida parapsilosis species complex in Eastern China: A 15-year retrospective study by ECIFIG","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11128","article-title":"Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance","volume":"7","author":"Healey","year":"2016","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6429","DOI":"10.1038\/s41467-020-20183-3","article-title":"An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris","volume":"11","author":"Iyer","year":"2020","journal-title":"Nat. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1093\/ofid\/ofz360.329","article-title":"National trends in the Japanese distribution of major Candida species causing candidemia during 2003\u20132017: A report by the epidemiological investigation committee for human mycoses in Japan","volume":"6","author":"Kakeya","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00232","article-title":"Prevalence and clonal distribution of azole-resistant Candida parapsilosis isolates causing bloodstream infections in a Large Italian hospital","volume":"10","author":"Martini","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/jac\/dkz400","article-title":"Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans","volume":"75","author":"Nishimoto","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059373","article-title":"Epidemiology of candidemia in Latin America: A laboratory-based survey","volume":"8","author":"Nucci","year":"2013","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41564-021-00875-2","article-title":"Candida pathogens induce protective mitochondria-associated type I interferon signalling and a damage-driven response in vaginal epithelial cells","volume":"6","author":"Pekmezovic","year":"2021","journal-title":"Nat. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of clinical and laboratory standards institute broth microdilution methods 2010 to 2012","volume":"50","author":"Pfaller","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1128\/AAC.02040-12","article-title":"Milbemycins: more than efflux inhibitors for fungal pathogens","volume":"57","author":"Silva","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/jac\/dkz029","article-title":"Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India","volume":"74","author":"Singh","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01516-19","article-title":"Epidemiological trends of fungemia in Greece with a focus on candidemia during the recent financial crisis: A 10-year survey in a tertiary care academic hospital and review of literature","volume":"64","author":"Siopi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1128\/AAC.01177-15","article-title":"Candida parapsilosis resistance to fluconazole: Molecular mechanisms and in vivo impact in infected Galleria mellonella larvae","volume":"59","author":"Souza","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02997","article-title":"An azole-resistant Candida parapsilosis outbreak: Clonal persistence in the intensive care unit of a Brazilian teaching hospital","volume":"9","author":"Thomaz","year":"2018","journal-title":"Front. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040259","article-title":"Environmental clonal spread of azole-resistant Candida parapsilosis with Erg11-Y132F mutation causing a large candidemia outbreak in a Brazilian cancer referral center","volume":"7","author":"Thomaz","year":"2021","journal-title":"J. Fungi"},{"key":"B35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12879-015-1086-6","article-title":"Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Infect. Dis."}],"container-title":["Frontiers in Fungal Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ffunb.2022.906681\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T23:03:55Z","timestamp":1659049435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ffunb.2022.906681\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":35,"alternative-id":["10.3389\/ffunb.2022.906681"],"URL":"https:\/\/doi.org\/10.3389\/ffunb.2022.906681","relation":{},"ISSN":["2673-6128"],"issn-type":[{"value":"2673-6128","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"article-number":"906681"}}